Assessment of Tuberculosis Treatment Strategies in HIV Patients: A Comparative Study of Two Healthcare Facilities in Oyo State, Nigeria

Tuberculosis (TB) and Human Immunodeficiency Virus (HIV) co-infection, particularly prevalent in Sub-Saharan Africa, significantly increases morbidity and mortality rates. The synergistic relationship between TB and HIV, often termed 'the cursed duet,' exacerbates the global health burden by elevating the risk of developing active TB among HIV-infected individuals. This co-infection accelerates disease progression, complicates treatment protocols, and strains healthcare systems. In Nigeria, a country ranking sixth globally in TB burden, the intersection of HIV and TB presents formidable public health and socio-economic challenges. Effective management of HIV/TB co-infection is critical to reducing morbidity and mortality, alleviating healthcare system burdens, and mitigating the economic impact on affected communities.